Mail

Australia markets close in 4 hours 25 minutes

ALL ORDS
7,256.90
-21.70(-0.30%)
ASX 200
7,052.30
-24.20(-0.34%)
AUD/USD
0.6425
+0.0000(+0.01%)
OIL
89.60
-0.08(-0.09%)
GOLD
1,933.60
-3.00(-0.15%)
Bitcoin AUD
40,846.57
-33.33(-0.08%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Cynata Therapeutics Limited (CYP.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

0.1350

+0.0100

(+8.00%)

As of 10:32AM AEST. Market open.

Currency in AUD

Valuation measures⁴

Market cap (intra-day)	22.45M
Enterprise value	6.29M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	1.34
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-0.39

Trading information

Stock price history

Beta (5Y monthly)	0.87
52-week change ³	-59.02%
S&P500 52-week change ³	18.92%
52-week high ³	0.3850
52-week low ³	0.1050
50-day moving average ³	0.1383
200-day moving average ³	0.2094

Share statistics

Avg vol (3-month) ³	100.14k
Avg vol (10-day) ³	18.11k
Shares outstanding ⁵	179.63M
Implied shares outstanding ⁶	179.63M
Float ⁸	132.16M
% held by insiders ¹	12.20%
% held by institutions ¹	24.98%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:20
Last split date ³	31 Oct 2013

Financial highlights

Fiscal year

Fiscal year ends	30 June 2023
Most-recent quarter (mrq)	30 June 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-899.97%

Management effectiveness

Return on assets (ttm)	-40.86%
Return on equity (ttm)	-70.17%

Income statement

Revenue (ttm)	1.65M
Revenue per share (ttm)	0.01
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	1.65M
EBITDA	-14.61M
Net income avi to common (ttm)	-14.28M
Diluted EPS (ttm)	-0.1000
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	16.17M
Total cash per share (mrq)	0.09
Total debt (mrq)	N/A
Total debt/equity (mrq)	N/A
Current ratio (mrq)	7.46
Book value per share (mrq)	0.09

Cash flow statement

Operating cash flow (ttm)	-14.28M
Levered free cash flow (ttm)	-9.38M